Quality of life and drug costs associated with switching antipsychotic medication to once-daily extended release quetiapine fumarate in patients with schizophrenia

Author： Järbrink Krister   Kreif Noemi   Benedict Agnes   Locklear Julie  

Publisher： Informa Healthcare

ISSN： 1473-4877

Source： Current Medical Research and Opinion, Vol.25, Iss.3, 2009-03, pp. : 709-716

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Switching from other antipsychotics to once-daily extended release quetiapine fumarate in patients with schizophrenia

By Ganesan S.   Agambaram V.   Randeree F.   Eggens I.   Huizar K.   Meulien D.    

Current Medical Research and Opinion, Vol. 24, Iss. 1, 2008-01 ,pp. : 21-32

Informa Healthcare

Access to resources Recommend Favorite

The long-term clinical benefit and effectiveness of switching to once-daily quetiapine extended release in patients with schizophrenia

By Chue P.   Malla A.   Bouchard R.-H.   Lessard S.   Ganesan S.   Stip E.   Johnson S.   Chen E.   Ahn Y.M.   Kim Y.S.   Robinson G.   Schweikert C.   Gendron A.   Eriksson H.    

Current Medical Research and Opinion, Vol. 29, Iss. 3, 2013-03 ,pp. : 227-239

Informa Healthcare

Access to resources Recommend Favorite

Long-term effectiveness of flexibly dosed paliperidone extended-release: comparison among patients with schizophrenia switching from risperidone and other antipsychotic agents

By Kim Eun Young   Chang Sung Man   Shim Joo Cheol   Joo Eun Jeong   Kim Jae Jin   Kim Yong Sik   Ahn Yong Min  

Current Medical Research and Opinion, Vol. 29, Iss. 10, 2013-10 ,pp. : 1231-1240

Informa Healthcare

Access to resources Recommend Favorite

Antipsychotic medication, functional outcome and quality of life in schizophrenia: focus on amisulpride

By Nuss Philippe   Tessier Cedric  

Current Medical Research and Opinion, Vol. 26, Iss. 4, 2010-04 ,pp. : 787-801

Informa Healthcare

Access to resources Recommend Favorite

Switching from oral risperidone to flexibly dosed oral paliperidone extended-release: core symptoms, satisfaction, and quality of life in patients with stable but symptomatic schizophrenia: the RISPALI study

By Gattaz Wagner F.   Campos João Alberto de Oliveira   Lacerda Acioly L.T.   Henna Elaine   Ruschel Sandra Inês   Bressan Rodrigo A.   de Oliveira Irismar Reis   Rocha Fábio Lopes   Grabowski Hamilton M.   Sacomani Ernindo   Louzã Mario R.   Quevedo João   Elkis Hélio   Filho Dirceu Zorzetto   Périco Cintia de Azevedo-Marques   Lawson Fábio Lorea   Appolinário José Carlos  

Current Medical Research and Opinion, Vol. 30, Iss. 4, 2014-04 ,pp. : 695-709

Informa Healthcare

Access to resources Recommend Favorite